Shattuck Labs Inc's Customers Performance

Name: Shattuck Labs Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

STTK

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


STTK's Source of Revenues		• List of STTK Customers

for the same period Shattuck Labs Inc

• List of STTK Customers

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Shattuck Labs Inc's Comment on Sales, Marketing and Customers

News about Shattuck Labs Inc Contracts

Shattuck Labs, a biopharmaceutical company focused on discovering and developing transformative therapies,...

Shattuck Labs Announces Promising Interim Data from Phase 1B Clinical Trial of SL-172154 in Combination with Azacitidine for the Treatment of HR-MDS and TP53 Mutant AML Shattuck Labs, a biopharmaceutical company focused on discovering and developing transformative therapies, has released its second quarter 2024 financial results along with significant business updates. At the forefront of these updates is the encouraging interim data from their ongoing Phase 1B dose-expansion clinical trial of SL-172154 in combination with Azacitidine (AZA) for treatment in patients with frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML). This data was presented at ...

Shattuck Labs Announces Promising Interim Results for SL-172154 Combination Therapy in High-Risk Myelodysplastic Synd...

In the ever-evolving landscape of oncology, the quest for novel therapies that demonstrate both efficacy and safety remains a paramount concern. Recently, Shattuck Labs has made significant strides in this realm, as evidenced by their latest results from an ongoing Phase 1B dose expansion clinical trial. The trial investigates the safety and efficacy of SL-172154 in combination with azacitidine (AZA), focusing on frontline higher-risk myelodysplastic syndromes (HR-MDS) and TP53 mutant (TP53m) acute myeloid leukemia (AML) patients. Promising Interim ResultsThe data reveal compelling findings, notably a 67% response rate (ORR) in frontline HR-MDS patients, a population that is notoriously challenging to treat...

Shattuck Labs Partners with Ono Pharmaceutical to Develop Innovative Bifunctional Fusion Proteins for Autoimmune and Inflammatory Diseases

In a groundbreaking move, Shattuck Labs, Inc. (Shattuck) has joined forces with Ono Pharmaceutical Co., Ltd. (Ono) to explore the potential of bifunctional fusion proteins as a novel therapeutic approach for patients suffering from autoimmune and inflammatory diseases. This strategic collaboration aims to leverage the expertise of both companies to develop innovative drugs that target specific pathways involved in these complex medical conditions.Background:Shattuck Labs is a leading clinical-stage biotechnology company that specializes in the development of bifunctional fusion proteins, a promising class of biologic medicine. These proteins possess the unique ability to simultaneously bind to two distinct t...

STTK's Stock Performance relative to it's Customers

STTK's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Shattuck Labs Inc	800.74	6.41	-49.87	40
SUBTOTAL	0.00	0.00	0.00	-

Sources: Shattuck Labs Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Shattuck Labs Inc’s corporate clients.
For your research, we’ve provided 9 tables on Shattuck Labs Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.